Premature Ejaculation and Erectile Dysfunction Together: Which Should Be Treated First?

A man books an appointment about premature ejaculation. He has tried a delay spray, then a course of tablets a friend recommended, and neither did much. Somewhere in the consultation, almost in passing, he mentions that his erections have not been what they were for a couple of years.

That detail changes everything. It very often turns out to be the actual problem, with the premature ejaculation a downstream consequence — and it explains why months of PE treatment produced so little.

This guide, part of the Lumora Wellness Patient Education Series, sets out how the two conditions interact, why treatment order matters more than treatment choice, and what the evidence supports for men who have both.

Why the Two Are So Often Confused

From the patient's side, both conditions present as the same lived experience: sex ends sooner than wanted. The internal mechanism differs completely, but the outward complaint can feel identical — which is why men frequently arrive having self-diagnosed the wrong one.

The clinical distinction is straightforward once examined:

• Erectile dysfunction is difficulty achieving or maintaining an erection sufficient for satisfactory intercourse
• Premature ejaculation is ejaculation occurring sooner than desired, with minimal stimulation, causing distress

A man losing his erection partway through may interpret the early end to intercourse as "finishing too quickly." Equally, a man with genuine PE may develop erectile difficulties secondary to the anxiety that builds around it. Sorting out which came first is the single most useful thing an assessment does.

How Common Is the Overlap?

Premature ejaculation affects an estimated 20–30% of men at some point, making it the most common male sexual complaint. Erectile dysfunction becomes progressively more common with age and cardiovascular risk.

The overlap between them is substantially greater than chance would predict. Systematic review evidence indicates a significant bidirectional association — men with ED are considerably more likely to report PE, and vice versa. In practice, a meaningful proportion of men presenting with one condition have some degree of the other.

Which means a consultation that examines only the complaint a man opens with will miss the fuller picture in a substantial number of cases.

How the Two Conditions Feed Each Other

The relationship runs in both directions, and understanding the direction in your own case determines the treatment sequence.

When ED Drives the PE

This is the more common pattern and the more clinically actionable one:

• Anticipatory rushing. A man who has experienced erections fading mid-intercourse learns — often without conscious decision — to hurry toward ejaculation while the erection holds
• Increased stimulation to compensate. Maintaining a partial erection may require more vigorous stimulation, which accelerates the ejaculatory reflex
• Performance anxiety. Heightened sympathetic arousal from anxiety about erectile failure shortens latency independently

When PE Drives the ED

• Repeated distressing episodes generate anticipatory anxiety, which is itself a well-recognised contributor to psychogenic erectile difficulty
• Avoidance of intimacy reduces frequency, and relationship strain compounds both complaints

When Something Underneath Drives Both

Occasionally a shared cause sits beneath the two. Thyroid dysfunction, low testosterone, prostatitis, poor metabolic health and certain medications can each contribute to both complaints. This is the scenario in which treating either symptom in isolation reliably disappoints. Our guide to erectile dysfunction causes beyond age covers the underlying contributors in more depth.

Getting the Diagnosis Right

Assessment is largely clinical, and more informative than most men expect:

• Detailed sexual history, including which complaint appeared first and whether PE is lifelong or acquired
• Intravaginal ejaculatory latency time (IELT) — patient-estimated or partner-timed
• Validated instruments — the Premature Ejaculation Diagnostic Tool (PEDT) and Premature Ejaculation Profile (PEP), alongside erectile function scoring
• Explicit screening for erectile dysfunction in every man presenting with PE — and for PE in every man presenting with ED
• Examination and, where indicated, hormonal, metabolic and prostate assessment

One question does much of the diagnostic work: if you masturbate, do you maintain a full erection and does ejaculation happen equally quickly? Rapid ejaculation with a firm erection during solo activity points toward primary PE. Difficulty maintaining rigidity in that setting points toward ED as the driver.

Why Erectile Dysfunction Is Usually Treated First

Established Care

When both conditions are present, established practice is to address the erectile dysfunction first. There are three reasons, and the third is the one most often missed.

• The PE frequently resolves on its own. Remove the anxiety about losing an erection and the rushing behaviour that developed around it often settles without PE-specific treatment
• ED treatment is well established and rapid. PDE5 inhibitors have a substantial evidence base and work quickly, so the question of whether the ED was driving the PE is answered within weeks rather than months
• SSRIs can worsen erectile function. This is the critical point. Reduced libido and erectile impairment are recognised effects of SSRI treatment. Prescribing an SSRI for PE in a man whose ED has not been addressed risks deepening the very problem underneath

That last point explains a great many disappointing treatment courses. A man is given a tablet for PE, his erections deteriorate further, and he concludes that nothing works. A structured assessment of both conditions prevents that sequence. Our erectile dysfunction treatment in Dubai page sets out how erectile function is evaluated and managed.

Treating PE Once Erectile Function Is Stable

Established Care

Where PE persists after erectile function is restored, the established options apply:

• Behavioural therapy — stop-start and squeeze techniques, sex therapy, pelvic floor training
• Topical anaesthetics — lidocaine-prilocaine cream or spray applied before intercourse
• Dapoxetine — a short-acting SSRI developed specifically for PE and approved for on-demand use in many countries including the UAE
• Daily or on-demand SSRIs (off-label) — paroxetine, sertraline, fluoxetine, used with the erectile caveat above firmly in mind

Combination approaches — topical plus oral plus behavioural — tend to outperform any single modality. For a man who has only ever tried one thing, this is often the simplest available gain.

Combination Regimens for Mixed PE and ED

Established Care

For men with genuinely coexisting PE and ED, treating both mechanisms concurrently is a recognised approach rather than an improvisation.

• PDE5 inhibitor plus SSRI regimens are described for mixed presentations, and in this specific group combination therapy is frequently more effective than either agent alone
• The PDE5 inhibitor restores erectile confidence while the SSRI extends latency — each addressing a different mechanism
• PDE5 inhibitors also appear to offer some benefit for ejaculatory latency in men with comorbid ED, likely through reduced performance anxiety and restored confidence rather than a direct ejaculatory effect
• Tramadol is described as an off-label alternative in selected cases, used cautiously given its dependency potential

These are prescription regimens requiring individual assessment for cardiovascular status, current medications and interaction risk. They are not suitable for self-assembly from separately sourced medication.

Where Newer Injectables Fit

Hyaluronic Acid Glans Augmentation

Emerging Research

Injecting hyaluronic acid gel into the glans penis is intended to dampen tactile hypersensitivity — a proposed driver of lifelong PE, targeting sensory input rather than serotonin signalling.

• A 2025 randomised comparative study of 60 men found HA glans injection significantly increased ejaculatory latency, with a larger effect than botulinum toxin in the same trial
• A dedicated randomised trial comparing HA using the Fanning technique against botulinum toxin A is underway, enrolling 80 men
• Effects are temporary — HA is gradually resorbed, so repeat treatment is typically required

The relevance to mixed presentations is limited. These approaches target the sensory and reflex mechanisms of lifelong PE. They do not address erectile dysfunction, and they are not a shortcut past the sequencing question. In a man whose PE is being driven by untreated ED, a glans injection addresses the wrong mechanism entirely.

Botulinum Toxin

Emerging Research

• Injected into the bulbospongiosus muscle to reduce the intensity of the ejaculatory reflex contraction
• Randomised trials show measurable IELT increases versus placebo, though the effect appears smaller and less consistent than HA in head-to-head data
• One placebo-controlled trial found it safe but did not demonstrate clear superiority over placebo for lifelong PE

PRP, Exosomes and Device-Based Approaches

Early / Experimental

• PRP for PE — interest extrapolated from use in ED and Peyronie's disease; direct trial evidence for PE remains very limited
• Exosomes and secretome — not yet studied in dedicated PE trials; any use for this indication is strictly exploratory. Our guide to exosome-based therapy for erectile dysfunction covers where this research actually stands
• Radiofrequency and cryotherapy to reduce glans sensitivity are described only in small case series
• Selective dorsal penile neurectomy has randomised evidence in carefully selected lifelong PE but is invasive and reserved for refractory cases

How the Evidence Compares

Approach	Evidence Base	Role in Mixed PE and ED
PDE5 inhibitor first	Extensive RCT evidence for ED	First-line; often resolves secondary PE
PDE5 inhibitor + SSRI	Studied in mixed presentations	Frequently superior to either alone in this group
Dapoxetine alone	Multiple large RCTs for PE	Use with caution if ED untreated
Topical anaesthetic	Multiple RCTs	Useful adjunct; no erectile downside
Behavioural therapy	Established	Addresses the anxiety loop linking both
HA glans augmentation	RCTs including 2025 comparative trial	Targets lifelong PE; does not address ED
PRP / exosomes for PE	Extrapolated; minimal direct data	Not established for this indication

Benefits and Limitations

Approach	Benefit	Limitation
Treating ED first	Often resolves PE without PE-specific treatment; fast answer	Requires accepting a staged approach rather than treating everything at once
Combination PDE5i + SSRI	Addresses both mechanisms concurrently	Two medication side-effect profiles; needs interaction review
Behavioural + topical	No systemic effects; no erectile downside	Requires consistency; modest ceiling effect
SSRI monotherapy	Well studied for PE specifically	Can reduce libido and worsen erectile function
HA glans augmentation	Good early efficacy signal; single visit	Temporary; no effect on erectile function

Safety Considerations

• SSRIs and dapoxetine — monitor for nausea, dizziness and rare mood effects; avoid combining with other serotonergic drugs. Reduced libido and erectile impairment are recognised effects and matter especially in men with coexisting ED
• PDE5 inhibitors — absolutely contraindicated with nitrate medication. Cardiovascular status must be assessed before prescribing
• Combination regimens — require review of all current medication for interactions, and should not be self-assembled
• Topical anaesthetics — partner sensitivity reactions are possible; condom use reduces transfer
• HA and botulinum toxin injections — bruising, transient swelling and injection discomfort are the main procedural risks; both should be performed by an experienced injector

How We Approach This at Lumora Wellness

Lumora Wellness is a Dubai-based centre for evidence-informed men's health, regenerative medicine and longevity care, operating under DHA-compliant clinical governance. The practice is led by Dr. S. S. Vasan, a UroAndrologist and Surgical Andrologist with 37 years of clinical experience, DHA Specialist Licence holder, founder of SASSM, and author of four Springer textbooks in Andrology.

Every man presenting with premature ejaculation is screened for erectile dysfunction, and every man presenting with erectile dysfunction is asked about ejaculatory control. We establish which complaint came first, whether PE is lifelong or acquired, and whether a shared underlying cause — hormonal, metabolic or inflammatory — is contributing to both.

Established therapy is optimised, usually in combination, before newer injectables enter the conversation. Where HA or botulinum toxin is appropriate, its temporary nature and current guideline status are stated plainly.

Lumora Wellness works alongside URO Diagnostic Clinic in Dubai Healthcare City and an international clinical and research network spanning andrology, reproductive medicine and regenerative therapeutics.

Explore our erectile dysfunction treatment in Dubai

Frequently Asked Questions

How do I know whether my problem is PE or ED?

The most useful indicator is what happens during solo activity. Rapid ejaculation with a firm, well-maintained erection suggests primary PE. Difficulty achieving or holding rigidity in that setting suggests ED is the driver. A proper assessment examines both rather than accepting the complaint at face value.

Will treating my erectile dysfunction fix the premature ejaculation too?

Frequently, yes — particularly where the PE is acquired and appeared after the erectile difficulties began. The rushing behaviour that developed as compensation often settles once erections are reliable. Where PE persists afterwards, it can then be assessed and treated accurately.

Can I take a PDE5 inhibitor and an SSRI together?

Combination regimens are used in clinical practice for mixed PE and ED and are often more effective than either alone in that group. They require individual assessment for cardiovascular status and drug interactions, and should be prescribed rather than assembled independently.

Can an SSRI make my erections worse?

Reduced libido and erectile impairment are recognised effects of SSRI treatment. This is precisely why coexisting ED is screened for before an SSRI is started for PE, and why a man whose erections deteriorate after beginning one should raise it rather than persevere.

My PE started only recently — does that mean something else is wrong?

Acquired PE is more often linked to an identifiable trigger than lifelong PE is. Coexisting erectile dysfunction, prostatitis, thyroid dysfunction and psychological factors are the common contributors, and identifying the trigger generally produces better results than treating the symptom alone.

Are the newer injectable treatments useful if I have both conditions?

They target the sensory and reflex mechanisms of lifelong PE and do nothing for erectile function. In a man whose PE is being driven by untreated ED, they address the wrong mechanism. They are better considered once erectile function is stable and PE persists independently.

Take the Next Step

Premature ejaculation and erectile dysfunction are both common, both treatable, and frequently present together. What determines the outcome is rarely which individual treatment is chosen — it is whether the assessment identified the right problem to treat first.

If you recognise your own situation in this, a consultation allows both conditions to be assessed together, along with any shared underlying contributors.

Book Your Private Consultation

Want the full picture on erectile dysfunction?

If ED is the primary issue, our pillar guide covers evaluation, treatment options and what to expect at each stage.

Read: Erectile Dysfunction Treatment in Dubai

Interested in non-surgical options?

For men who prefer to avoid medication or have not responded to it, several non-invasive approaches are available with varying levels of evidence behind them.

Read: Non-Surgical Therapies for Erectile Dysfunction

Curious about what is genuinely new?

Our companion guides review recent advances in both conditions, with each approach placed in an honest evidence tier.

Read: Recent Advances in Erectile Dysfunction

References

1. Corona G, Rastrelli G, Limoncin E, et al. Interplay Between Premature Ejaculation and Erectile Dysfunction: A Systematic Review and Meta-Analysis. The Journal of Sexual Medicine. 2015;12(12):2291–2300.
2. McMahon CG, Stuckey BGA, Andersen M, et al. Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation. The Journal of Sexual Medicine. 2005;2(3):368–375.
3. Salonia A, Bettocchi C, Carvalho J, et al. EAU Guidelines on Sexual and Reproductive Health. European Association of Urology.
4. Hyaluronic Acid vs Botulinum Toxin Injection in Treatment of Lifelong Drug-Resistant Premature Ejaculation: Randomized Study. ClinicalTrials.gov NCT07236632, 2025.
5. Hyaluronic acid versus botulinum-A toxin injection in the treatment of premature ejaculation: a comparative study. Scientific Reports. 2025.
6. Effect of bulbospongiosus muscle injection with botulinum-A toxin for treatment of lifelong premature ejaculation: a randomized controlled trial. International Journal of Impotence Research. 2024.
7. Henriques et al. A systematic review on administration of botulinum toxin in the management of male sexual dysfunctions. Andrology. 2025.
8. Abdallah H, Abdelnasser T, Hosny H, et al. Treatment of premature ejaculation by glans penis augmentation using hyaluronic acid gel: a pilot study. Andrologia. 2012;44:650–653.